Sign in
686 EFFECTS ON PRURITUS AND SLEEP DISTURBANCE IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS (PBC) AFTER 1 YEAR OF TREATMENT WITH SELADELPAR, A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR DELTA AGONIST: RESULTS OF AN OPEN-LABEL PHASE 2 STUDY
Journal article   Peer reviewed

686 EFFECTS ON PRURITUS AND SLEEP DISTURBANCE IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS (PBC) AFTER 1 YEAR OF TREATMENT WITH SELADELPAR, A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR DELTA AGONIST: RESULTS OF AN OPEN-LABEL PHASE 2 STUDY

Andreas E Kremer, Marlyn J Mayo, Christopher L Bowlus, Guy Neff, Mark G Swain, Michael Galambos, Aparna Goel, Palak Trivedi, Gideon Hirschfield, Richard Aspinall, …
Gastroenterology (New York, N.Y. 1943), Vol.158(6), pp.S-1284-S-1285
2020-05

Metrics

13 Record Views

Details